Dr. Thomas Emig, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Wake Forest University School of Medicine (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 454
Licensed in Alabama since 1994, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: Wake Forest University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
AL license 18215 (first issued 1994; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Dch Regional Medical Center Tuscaloosa, AL
- Fayette Medical Center Fayette, AL
Medical groups
- Capstone Health Services Foundation PC (161 clinicians)
- Neurology Consultants of Tuscaloosa, P.c. (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 454
- Services billed
- 6,450
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 389 | 266 |
| New patient office or other outpatient visit, 45-59 minutes | 105 | 105 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 69 | 55 |
| Established patient office or other outpatient visit, 20-29 minutes | 55 | 54 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 42 | 41 |
| Nerve conduction, 7-8 studies | 34 | 34 |
| Nerve conduction, 9-10 studies | 29 | 29 |
| Mri scan of brain without contrast | 27 | 27 |
| Nerve conduction, 13 or more studies | 19 | 19 |
| New patient office or other outpatient visit, 30-44 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levetiracetam Other prescribers in Tuscaloosa, AL | 371 |
| Donepezil Hcl Other prescribers in Tuscaloosa, AL | 281 |
| Topiramate Other prescribers in Tuscaloosa, AL | 276 |
| Gabapentin Other prescribers in Tuscaloosa, AL | 259 |
| Rizatriptan (rizatriptan benzoate) Other prescribers in Tuscaloosa, AL | 186 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Tuscaloosa, AL | 173 |
| Lamotrigine Other prescribers in Tuscaloosa, AL | 152 |
| Lacosamide Other prescribers in Tuscaloosa, AL | 129 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Tuscaloosa, AL | 124 |
| Alprazolam Other prescribers in Tuscaloosa, AL | 120 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 45 companies reported 239 payments worth $4,478 in total to this clinician.
| AbbVie Inc. | $688 |
|---|---|
| Pfizer Inc. | $555 |
| Biogen, Inc. | $265 |
| Neurocrine Biosciences, Inc. | $262 |
| Eisai Inc. | $178 |
| Csl Behring | $166 |
| Novartis Pharmaceuticals Corporation | $163 |
| Merz Pharmaceuticals, LLC | $146 |
| Food and Beverage | $4,443 |
|---|---|
| Education | $35.13 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Csl Behring May 29, 2025 | Education Hizentra · Immunology · in-kind | $11.71 |
| Csl Behring Jun 3, 2025 | Education Hizentra · Immunology · in-kind | $11.71 |
| Csl Behring Jul 3, 2025 | Education Hizentra · Immunology · in-kind | $11.71 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.